Carotid Artery Ultrasonographic Assessment in Patients from the Fremantle Diabetes Study Phase II with Carotid Bruits Detected by Electronic Auscultation

Knapp, A; Cetrullo, Violetta; Sillars, Brett A.; Lenzo, Nat; Davis, Wendy A.; Davis, Timothy

doi:10.1089/dia.2014.0048

Cited by 4 publications

(5 citation statements)

References 37 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The one exception was the diagnosis of carotid arterial disease, but this may be diagnosed more frequently in other countries based on the presence of a carotid bruit without confirmatory ultrasonography that may reveal causes other than atherosclerosis, such as carotid arterial tortuosity. 15 A detailed assessment of these considerations was beyond the scope of the data collected in CAPTURE.…”

Section: Discussionmentioning

confidence: 99%

“…For example, more Australians may have relatively high rates of CHD, PAD, heart failure and arrhythmias because of the relative accessibility to tests such as electrocardiography, coronary angiography, peripheral arterial Doppler studies and plasma N‐terminal pro‐B‐type natriuretic peptide (NT proBNP) in a comparatively well‐resourced health system. The one exception was the diagnosis of carotid arterial disease, but this may be diagnosed more frequently in other countries based on the presence of a carotid bruit without confirmatory ultrasonography that may reveal causes other than atherosclerosis, such as carotid arterial tortuosity 15 . A detailed assessment of these considerations was beyond the scope of the data collected in CAPTURE.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Cardiovascular disease management in Australian adults with type 2 diabetes: insights from the CAPTURE study

Davis

Colman

Hespe

et al. 2022

Internal Medicine Journal

View full text Add to dashboard Cite

BackgroundType 2 diabetes (T2D) is a well‐recognised cardiovascular disease (CVD) risk factor, and recent guidelines for the management of T2D include consideration of CVD risk.AimTo assess whether contemporary clinical management of Australians with T2D is in accord with recent national and international guidelines.MethodsThis Australia‐specific analysis of the CAPTURE study, a non‐interventional, cross‐sectional study included adults diagnosed with T2D ≥180 days prior to providing informed consent and visiting primary or specialist care. Main outcome measures were the use of blood glucose‐lowering medications (BGLMs), BGLMs with proven cardiovascular benefits and other CVD medications, stratified by CVD status and care setting.ResultsOf 824 Australian participants in the CAPTURE sample, 332 (40.3%) had CVD. Oral BGLMs were used by 83.9% of all participants, most commonly metformin (76.0%), dipeptidyl peptidase‐4 inhibitors (28.8%), sodium‐glucose cotransporter‐2 inhibitors (SGLT2is; 21.8%) and sulfonylureas (21.7%). Insulin was used by 29.2% of participants. BGLMs with proven CV benefit were used by 22.6%; glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) were less commonly used than SGLT2is in all CVD groups, but these drug classes were more often prescribed in specialist than primary care (SGLT2is 25.4 vs 20.7%, GLP‐1 RAs 3.2 vs 0.8% respectively). Use of non‐BGLMs for CVD risk reduction appeared consistent with guidelines.ConclusionsUse of BGLMs with CVD benefits appears low in Australia, irrespective of CVD status. This likely reflects the delay in translation of clinical evidence into contemporary care and prescribing restrictions.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Cardiovascular disease management in Australian adults with type 2 diabetes: insights from the CAPTURE study

Davis

Colman

Hespe

et al. 2022

Internal Medicine Journal

View full text Add to dashboard Cite

show abstract

“…Estimated glomerular filtration rate (eGFR) was calculated using the Chronic Kidney Disease Epidemiology Collaboration equation. 31 Briefly, the stethoscope was applied over six designated regions (upper and lower carotids bilaterally, aortic and pulmonary areas) and the sounds recorded for later analysis by one of two study physicians. 30 Peripheral arterial disease was considered present if the anklebrachial index was ≤0.90 in either leg or a diabetes-related amputation was present.…”

Section: Clinical Assessmentmentioning

confidence: 99%

“…Carotid bruits were detected noninvasively using electronic auscultation with a Littman 3000 stethoscope (3M, North Ryde, NSW, Australia) as previously described. 31 Briefly, the stethoscope was applied over six designated regions (upper and lower carotids bilaterally, aortic and pulmonary areas) and the sounds recorded for later analysis by one of two study physicians.…”

Section: Clinical Assessmentmentioning

confidence: 99%

Glycaemic control and mortality in older people with type 2 diabetes: The Fremantle Diabetes Study Phase II

Bruce

Davis

2018

Diabetes Obesity Metabolism

Self Cite

View full text Add to dashboard Cite

show abstract

“…A carotid bruit is a sound created by turbulent blood in a carotid artery, often caused by narrowing that in turn is produced by atherosclerotic plaques. Knapp et al looked at the effectiveness of carotid bruit detection by electronic auscultation[47]. Out of 1,371 patients in this study, 84 were found to have carotid bruits by electronic auscultation.…”

mentioning

confidence: 85%

A Survey of Challenges and Opportunities in Sensing and Analytics for Cardiovascular Disorders

Hurley¹,

Spatz²,

Krumholz³

et al. 2019

Preprint

View full text Add to dashboard Cite

Cardiovascular disorders account for nearly 1 in 3 deaths in the United States. Care for these disorders are often determined during visits to acute care facilities, such as hospitals. While the length of stay in these settings represents just a small proportion of patients' lives, they account for a disproportionately large amount of decision making. To overcome this bias towards data from acute care settings, there is a need for longitudinal monitoring in patients with cardiovascular disorders. Longitudinal monitoring can provide a more comprehensive picture of patient health, allowing for more informed decision making. This work surveys the current field of sensing technologies and machine learning analytics that exist in the field of remote monitoring for cardiovascular disorders. We highlight three primary needs in the design of new smart health technologies: 1) the need for sensing technology that can track longitudinal trends in signs and symptoms of the cardiovascular disorder despite potentially infrequent, noisy, or missing data measurements; 2) the need for new analytic techniques that model data captured in a longitudinal, continual fashion to aid in the development of new risk prediction techniques and in tracking disease progression; and 3) the need for machine learning techniques that are personalized and interpretable, allowing for advancements in shared clinical decision making. We highlight these needs based upon the current state-of-the-art in smart health technologies and analytics and discuss the ample opportunities that exist in addressing all three needs in the development of smart health technologies and analytics applied to the field of cardiovascular disorders and care.

show abstract

Carotid Artery Ultrasonographic Assessment in Patients from the Fremantle Diabetes Study Phase II with Carotid Bruits Detected by Electronic Auscultation

Cited by 4 publications

References 37 publications

Cardiovascular disease management in Australian adults with type 2 diabetes: insights from the CAPTURE study

Cardiovascular disease management in Australian adults with type 2 diabetes: insights from the CAPTURE study

Glycaemic control and mortality in older people with type 2 diabetes: The Fremantle Diabetes Study Phase II

A Survey of Challenges and Opportunities in Sensing and Analytics for Cardiovascular Disorders

Contact Info

Product

Resources

About